Dr. Raman Govindarajan is the R&D Head-India at Sanofi, a leading global pharmaceuticals company, responsible for developing an R&D strategy for India in line with Sanofi's regional and global needs. Dr. Raman is responsible for building research and development partnerships with academia and Industry across the value chain of Drug discovery and development and sourcing novel technologies for Sanofi. He is a medical doctor with residency training in internal medicine and also holds a PhD in cell biology. After this training he spent four years at Cornell University'Medical College as a post-doctoral fellow in cell biology working on the cellular basis of hypertension and studying a unique myosin heavy chain gene in muscular dystrophy. On his return to India, he joined Unilever where he had a successful stint of over sixteen years in cell biology and molecular biology of skin, with key focus on anti-aging, pigmentation, irritation, allergy and tumorigenesis and as Head of Unilever's Environmental Safety Laboratory where he steered research and service in Toxicology and Microbiology.
His other professional stints include research and regulatory affairs leadership positions at Johnson & Johnson Asia Pacific, Singapore. Dr. Govindarajan has also been an Adjunct Associate Professor of Biochemistry at the National University of Singapore.
Prior to Sanofi, he was Senior Vice President for Discovery Biology, Development and Translational Medicine at Jubilant Biosys and Jubilant Innovation in India. Dr. Raman has published more than 100 internal scientific reports and has 24 filed patents, 25 peer reviewed publications and 45 conference presentations to his name. His key interests are in novel drug discovery and development in Oncology and metabolic diseases